Crf
Payments companies reported to CMS as associated with Crf. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Crf, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Crf
These are the largest totals companies reported as associated with Crf. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Agustin Andrade | Miami Beach, FL | $19,356.14 | |
| Saka Kazeem | Brooklyn, NY | Endocrinology, Diabetes & Metabolism | $18,328.63 |
| Alireza Falahati-Nini | Salt Lake City, UT | Endocrinology, Diabetes & Metabolism | $18,003.60 |
| Sean Nikravan | Newport Beach, CA | Endocrinology, Diabetes & Metabolism | $18,000.00 |
| Jules Aljammal | Issaquah, WA | Endocrinology, Diabetes & Metabolism | $14,001.22 |
| Shahzad Ahmad | Salt Lake City, UT | Endocrinology, Diabetes & Metabolism | $13,916.68 |
| Shraga Goldberg | Boston, MA | Diagnostic Radiology | $8,030.00 |
| Iftikhar Malik | Appleton, WI | Endocrinology, Diabetes & Metabolism | $6,000.00 |
| Timothy Huber | Portland, OR | Vascular & Interventional Radiology | $3,000.00 |
| Maria Incer Obando | Belle Chasse, LA | Endocrinology, Diabetes & Metabolism | $1,312.50 |
Prescribed Crf?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.